Results 161 to 170 of about 674,964 (218)

CG>TG mutation frequency as negative predictor of homologous recombination deficiency in ovarian and breast cancer. [PDF]

open access: yesCommun Biol
Romanovsky E   +8 more
europepmc   +1 more source

A molecular array for 10-second diagnosis of common spinal tumor types with picosecond infrared laser mass spectrometry. [PDF]

open access: yesNeuro Oncol
Fiorante A   +14 more
europepmc   +1 more source

Histological Typing of Breast Tumors [PDF]

open access: possibleTumori Journal, 1982
The WHO Histological Classification of Breast Tumors, published in 1968 has been completely revised. This second edition provides a recommended nomenclature, definitions and code numbers for both tumors and tumor-like lesions. It aims at promoting uniformity in recording and reporting diagnoses in order to facilitate international and other ...
J. Sugar   +12 more
openaire   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Sonography of ovarian tumors: predictability of tumor type

American Journal of Roentgenology, 1983
One hundred six ovarian neoplasms were evaluated with respect to size, echogenic characteristics, and percentage of echogenic material to determine if sonography could differentiate between malignant and benign tumors and if histology could be determined.
D Rochester   +4 more
openaire   +3 more sources

Neurogenic Tumors in the Abdomen: Tumor Types and Imaging Characteristics

RadioGraphics, 2003
There is a broad spectrum of neurogenic tumors that involve the abdomen. These tumors can be classified as those of (a) ganglion cell origin (ganglioneuromas, ganglioneuroblastomas, neuroblastomas), (b) paraganglionic system origin (pheochromocytomas, paragangliomas), and (c) nerve sheath origin (neurilemmomas, neurofibromas, neurofibromatosis ...
Hae Giu Lee   +5 more
openaire   +3 more sources

Firefighters for the Wrong Type of Inflammation in Tumors

Cancer Discovery, 2021
Abstract Summary: In this issue of Cancer Discovery, Pelly and colleagues show that inhibition of prostaglandin E2 synthesis or its activity on EP2 and EP4 receptors synergizes with anti–PD-1 immunotherapy and triggers a potent intratumoral IFNγ response in mouse models and in fresh surgical human ...
Ignacio Melero   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy